$AMRN
AMARIN CORP PLC\UK

2018 Form 10-K Financial Statement

#000156459019004655 Filed on February 27, 2019

View on sec.gov

Income Statement

Concept 2018 2017 Q4 2017 Q3
Revenue $229.2M $53.87M $47.36M
YoY Change 26.56% 39.2% 44.68%
Cost Of Revenue $54.54M $13.40M $11.90M
YoY Change 21.34% 31.37% 40.81%
Gross Profit $174.7M $40.40M $35.40M
YoY Change 28.29% 41.75% 45.78%
Gross Profit Margin 76.2% 75.0% 74.75%
Selling, General & Admin $227.0M $35.60M $33.20M
YoY Change 68.71% 14.1% 27.39%
% of Gross Profit 129.96% 88.12% 93.79%
Research & Development $55.90M $11.90M $10.70M
YoY Change 18.54% 16.67% -20.68%
% of Gross Profit 32.0% 29.46% 30.23%
Depreciation & Amortization $670.0K $170.0K $180.0K
YoY Change 570.0% -15.0% -5.26%
% of Gross Profit 0.38% 0.42% 0.51%
Operating Expenses $282.9M $47.60M $43.90M
YoY Change 55.69% 14.98% 11.0%
Operating Profit -$108.2M -$7.200M -$8.500M
YoY Change 137.57% -44.19% -44.33%
Interest Expense $8.872M -$2.200M -$2.400M
YoY Change -9.15% 0.0% -52.48%
% of Operating Profit
Other Income/Expense, Net -$326.0K $0.00 $0.00
YoY Change -540.54% -100.0% -100.0%
Pretax Income -$116.3M -$9.400M -$10.80M
YoY Change 112.25% -38.16% -35.66%
Income Tax $96.00K $5.600M $0.00
% Of Pretax Income
Net Earnings -$116.4M -$22.47M -$10.83M
YoY Change 71.58% -18.17% -31.37%
Net Earnings / Revenue -50.8% -41.71% -22.86%
Basic Earnings Per Share -$0.39 -$0.08 -$0.04
Diluted Earnings Per Share -$0.39 -$0.08 -$0.04
COMMON SHARES
Basic Shares Outstanding 297.2M 270.8M
Diluted Shares Outstanding 297.2M 270.8M

Balance Sheet

Concept 2018 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $249.2M $73.60M $79.10M
YoY Change 238.59% -25.13% -32.74%
Cash & Equivalents $249.2M $73.64M $79.69M
Short-Term Investments
Other Short-Term Assets $4.400M $4.100M $4.800M
YoY Change 7.32% -46.05% -23.81%
Inventory $57.80M $30.26M $28.60M
Prepaid Expenses
Receivables $66.50M $45.32M $34.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $378.0M $153.3M $147.0M
YoY Change 146.58% 4.75% -8.8%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $28.00K $0.00
YoY Change -64.1% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $174.0K $11.30M
YoY Change 0.0% -76.52% 1556.89%
Total Long-Term Assets $7.700M $8.328M $19.60M
YoY Change -7.23% -59.72% -40.1%
TOTAL ASSETS
Total Short-Term Assets $378.0M $153.3M $147.0M
Total Long-Term Assets $7.700M $8.328M $19.60M
Total Assets $385.7M $161.6M $166.6M
YoY Change 138.68% -3.23% -14.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.60M $25.16M $15.80M
YoY Change 49.21% 314.96% 130.19%
Accrued Expenses $76.50M $58.90M $51.60M
YoY Change 42.46% 56.23% 34.73%
Deferred Revenue $1.644M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $34.20M $22.35M $20.40M
YoY Change 50.0% 40.17% 51.44%
Total Short-Term Liabilities $157.3M $108.5M $90.10M
YoY Change 44.98% 42.34% 19.95%
LONG-TERM LIABILITIES
Long-Term Debt $46.10M $70.83M $104.5M
YoY Change -53.81% -16.82% 17.89%
Other Long-Term Liabilities $30.00M $1.150M $18.20M
YoY Change 63.93% 61.97% 2389.74%
Total Long-Term Liabilities $76.10M $71.98M $122.7M
YoY Change -35.56% -16.17% 37.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $157.3M $108.5M $90.10M
Total Long-Term Liabilities $76.10M $71.98M $122.7M
Total Liabilities $233.4M $226.7M $212.7M
YoY Change 2.96% 28.76% 19.01%
SHAREHOLDERS EQUITY
Retained Earnings -$1.272B
YoY Change 5.64%
Common Stock $1.187B
YoY Change 1.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.229M
YoY Change 182.31%
Treasury Stock Shares $1.697M
Shareholders Equity $152.3M -$65.10M -$46.10M
YoY Change
Total Liabilities & Shareholders Equity $385.7M $161.6M $166.6M
YoY Change 138.68% -3.23% -14.08%

Cashflow Statement

Concept 2018 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$116.4M -$22.47M -$10.83M
YoY Change 71.58% -18.17% -31.37%
Depreciation, Depletion And Amortization $670.0K $170.0K $180.0K
YoY Change 570.0% -15.0% -5.26%
Cash From Operating Activities -$94.70M -$2.140M -$6.280M
YoY Change 188.4% -88.92% -66.45%
INVESTING ACTIVITIES
Capital Expenditures $58.00K $0.00 $0.00
YoY Change 383.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$58.00K $0.00 $0.00
YoY Change 383.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $264.8M
YoY Change
Debt Paid & Issued, Net $14.69M
YoY Change 342.2%
Cash From Financing Activities 271.3M -3.300M -110.0K
YoY Change 3193.88% -100.17%
NET CHANGE
Cash From Operating Activities -94.70M -2.140M -6.280M
Cash From Investing Activities -58.00K 0.000 0.000
Cash From Financing Activities 271.3M -3.300M -110.0K
Net Change In Cash 176.5M -5.440M -6.390M
YoY Change -817.03% -71.84% -114.17%
FREE CASH FLOW
Cash From Operating Activities -$94.70M -$2.140M -$6.280M
Capital Expenditures $58.00K $0.00 $0.00
Free Cash Flow -$94.76M -$2.140M -$6.280M
YoY Change 188.47% -88.92% -66.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0000897448
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0218
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0177
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0107
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.71
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.73
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Trading Symbol
TradingSymbol
AMRN
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.83
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0201
CY2018 dei Document Type
DocumentType
10-K
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0170
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.92
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.82
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.86
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-326000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116349000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44952000
CY2016 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130084000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
181104000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54543000
CY2018 us-gaap Gross Profit
GrossProfit
174671000
CY2016Q1 amrn Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-127552000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64613000
CY2016 us-gaap Gross Profit
GrossProfit
95721000
CY2016 us-gaap Operating Expenses
OperatingExpenses
161347000
CY2017 us-gaap Gross Profit
GrossProfit
136152000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
226996000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47158000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49975000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229214000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
250727000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
21527000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63126000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24614000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8710000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74237000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98851000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107561000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
17241000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
850000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-116445000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-86350000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76381000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-67865000
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
false
CY2018Q2 dei Entity Public Float
EntityPublicFloat
902000000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249227000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73637000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1500000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66523000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45318000
CY2018Q4 us-gaap Inventory Net
InventoryNet
57802000
CY2017Q4 us-gaap Inventory Net
InventoryNet
30260000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2945000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3455000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
377997000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
153270000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34240000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
157263000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46108000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10523000
CY2018Q4 us-gaap Liabilities
Liabilities
233384000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
21850000
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10413000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1388532000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
152330000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385714000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2018Q4 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
289317460
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55900000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
289317460
CY2018Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
28931746
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2018Q4 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329110863
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
325850013
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3260850
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134549000
CY2018 us-gaap Operating Expenses
OperatingExpenses
282896000
CY2017 us-gaap Operating Expenses
OperatingExpenses
181707000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-108225000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-45555000
CY2016 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8170000
CY2017 us-gaap Interest Expense
InterestExpense
9766000
CY2016 us-gaap Interest Expense
InterestExpense
18677000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
429000
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
234000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-482000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54818000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13047000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9969000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
17083000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
1753000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
1457000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111372000
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34363000
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
9373000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26402000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
638000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1207000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
14690000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6184000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
131389000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24108000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
69700000
CY2018Q4 amrn Deferred Tax Assets Operating Loss Carryforwards Change In Amount
DeferredTaxAssetsOperatingLossCarryforwardsChangeInAmount
78300000
CY2018Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
8400000
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:13pt;margin-left:2.26%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Concentration of Credit Risk </font></p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in financial institutions believed to be of high-credit quality. </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant portion of the Company&#8217;s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. Three customers individually accounted for 10% or more of the Company&#8217;s gross product sales. Customers A, B, and C accounted for 31%, 30%, and 27%, respectively, of gross product sales for the year ended December&#160;31, 2018 and represented 26%, 24%, and 39%, respectively, of the gross accounts receivable balance as of December&#160;31, 2018. Customers A, B, and C accounted for 27%, 33%, and 28%, respectively, of gross product sales for the year ended December&#160;31, 2017 and represented 27%, 21%, and 41%, respectively, of the gross accounts receivable balance as of December&#160;31, 2017.<font style="font-size:12pt;">&#160;</font>The Company has not experienced any significant write-offs of its accounts receivable. </p>
CY2017 us-gaap Restricted Stock Expense
RestrictedStockExpense
7000000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25700000
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2018 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
8200000
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7000000
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
6600000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.09
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.04
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.62
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.91
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.32
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7480000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8126000
CY2017Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
481000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
22348000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
208768000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1282762000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
977866000
CY2018Q4 us-gaap Assets
Assets
385714000
CY2017Q4 us-gaap Assets
Assets
161598000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
37632000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25155000
CY2018Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
84171000
CY2017Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
58902000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1220000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1644000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
108530000
CY2017Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
28992000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
70834000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19490000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17192000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1150000
CY2017Q4 us-gaap Liabilities
Liabilities
226698000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
24364000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
246663000
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4229000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1271869000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-65100000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
161598000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2017Q4 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
328184640
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
328184640
CY2017Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
32818464
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2017Q4 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
272719044
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
271022011
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1697033
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-65626000
CY2018 us-gaap Interest Expense
InterestExpense
8872000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
1074000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
96000
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
297237000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
270652000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211874000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
297237000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
270652000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211874000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-129191000
CY2016Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
1639000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
127436000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
287000
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
29369000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1094000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13602000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-9058000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
638000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2767000
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-39000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13952000
CY2018Q1 amrn Stockholders Equity Adjusted Balance
StockholdersEquityAdjustedBalance
-65318000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
264840000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1043000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6028000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26402000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6184000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18662000
CY2018 us-gaap Profit Loss
ProfitLoss
-116445000
CY2017 us-gaap Profit Loss
ProfitLoss
-67865000
CY2016 us-gaap Profit Loss
ProfitLoss
-86350000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
62000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
138000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
18806000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
13960000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
13613000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2183000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2332000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7783000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3831000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-567000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
645000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11082000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8798000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21205000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25333000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6171000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27542000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9753000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1522000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-510000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
567000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-310000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-6491000
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-6205000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1656000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1221000
CY2016 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
884000
CY2018 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
37602000
CY2017 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
40267000
CY2016 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
8705000
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
440000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
375000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94703000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32837000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71815000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000
CY2017 amrn Proceeds From Issuance Of Exchangeable Debt
ProceedsFromIssuanceOfExchangeableDebt
30000000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
264840000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64613000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1043000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
287000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
39000
CY2017 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
15107000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3322000
CY2018 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
121000
CY2016 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
680000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2767000
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1094000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
271251000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8235000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
176490000
CY2018 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
29490000
CY2016 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
128115000
CY2018 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2514000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:13pt;margin-left:2.26%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates </font></p> <p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounting estimates are based on historical experience and other factors that are considered reasonable under the circumstances. Estimates are used in determining such items as provisions for sales returns, rebates and incentives, chargebacks, and other sales allowances; depreciable/amortizable lives; asset impairments; valuation allowance on deferred taxes; probabilities of achievement of performance conditions for certain equity awards; amounts recorded for licensing revenue; contingencies and accruals; and valuations of derivative and long-term debt instruments. Because of the uncertainties inherent in such estimates, actual results may differ from these estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. </p>
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
646000
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-116445000
CY2017 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-67865000
CY2016 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-86350000
CY2018 amrn Number Of Patients Enrolled And Randomized In Study
NumberOfPatientsEnrolledAndRandomizedInStudy
8179
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
0
CY2018 amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
86133000
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
57802000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4250000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14142000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7044000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
8590000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
10844000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35357000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12372000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
58089000
CY2017Q4 us-gaap Inventory Gross
InventoryGross
30260000
CY2018Q4 us-gaap Inventory Adjustments
InventoryAdjustments
287000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
297237000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
270652000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
211874000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2018Q4 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
33602000
CY2017Q4 amrn Long Term Debt Current Net Of Accrued Interest
LongTermDebtCurrentNetOfAccruedInterest
21569000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
79710000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
92403000
CY2018 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P11Y7M6D
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4144000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3498000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
646000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
646000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
646000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
646000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
138000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
839000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
816000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
96000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1965000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1171000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
902000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
844000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2018Q4 us-gaap Purchase Obligation
PurchaseObligation
53000000
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q1 amrn Private Placement Closing Date
PrivatePlacementClosingDate
2015-03-30
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
52800000
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2017 us-gaap Depreciation
Depreciation
100000
CY2016 us-gaap Depreciation
Depreciation
100000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12170000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8298000
CY2017Q4 amrn Research And Development Accrued Expense Current
ResearchAndDevelopmentAccruedExpenseCurrent
1772000
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
20003000
CY2017Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9230000
CY2018Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
44286000
CY2017Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
34445000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7712000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5157000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
200000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
0
CY2018Q4 amrn Operating Leases Future Minimum Payments Due In Three Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsAndThereafter
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
200000
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.1
CY2015Q1 us-gaap Share Price
SharePrice
2.39
CY2015Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
31300000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19263038
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8138305
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
356656
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1734000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1633000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1550000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
296000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
762000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
20000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5547000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
121000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
83000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6815000
CY2018Q4 amrn Deferred Tax Liabilities Subject To Expiration
DeferredTaxLiabilitiesSubjectToExpiration
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13583000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2075000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8115000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1769000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1033000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
92000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
196000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3058000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1668000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1164000
CY2018 amrn Income Tax Reconciliation Windfall Tax Benefit
IncomeTaxReconciliationWindfallTaxBenefit
7684000
CY2017 amrn Income Tax Reconciliation Windfall Tax Benefit
IncomeTaxReconciliationWindfallTaxBenefit
1182000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1968000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5760000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4001000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1325000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-487000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-334000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-5435000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-16306000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-143000
CY2018 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
8728000
CY2017 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
22115000
CY2016 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
13276000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29087000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13698000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19039000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
9796000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3071000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
4667000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8728000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
22115000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13276000
CY2018 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
337000
CY2016 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
-668000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1438000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1177000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1689000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
6736000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
5788000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
4524000
CY2017 amrn Tax Cuts And Jobs Act Of2017 Change In Tax Rate Reconciliation Change In Tax Reform
TaxCutsAndJobsActOf2017ChangeInTaxRateReconciliationChangeInTaxReform
7398000
CY2018 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
5711000
CY2017 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
-12554000
CY2016 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
7385000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-404000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1635000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1573000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
267000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-17000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1922000
CY2018 amrn Income Tax Reconciliation Tax Reserve
IncomeTaxReconciliationTaxReserve
4956000
CY2018 amrn Income Tax Reconciliation Long Term Debt Royalty Bearing Instrument
IncomeTaxReconciliationLongTermDebtRoyaltyBearingInstrument
-880000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
119355000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
110715000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8113000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12446000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7816000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6378000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
6344000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3587000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
141628000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
133126000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.53
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.27
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
140117000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1511000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1737000
CY2018Q4 amrn Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
1011000
CY2017Q4 amrn Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
1145000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
500000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
592000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1511000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1737000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109274000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13609000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11466000
CY2018 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-4881000
CY2017 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
10649000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4363000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1058000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12415000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
18921000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
11463000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.26
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.82
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.39
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.40
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.24
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y6M
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
188022000
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
125395000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
184900000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.82
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.09
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.62
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7700000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7100000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6500000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0300
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.20
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.43
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.12
CY2018 us-gaap Restricted Stock Expense
RestrictedStockExpense
10600000
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
7000000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
700000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43919000
CY2017Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34637000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52643000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45241000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55323000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47360000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77330000
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
53866000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-24095000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-20941000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-34210000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-13634000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-24471000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-10825000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-33670000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-22465000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2018Q4 amrn Accrued Co Promotion Tail Payments
AccruedCoPromotionTailPayments
17800000
CY2018Q4 amrn Cash Discount Percent
CashDiscountPercent
0.02
CY2016Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
27198000
CY2017 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
178531000
CY2017 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
1075000
CY2017 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
132385000
CY2017 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
24176000
CY2017Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
48093000
CY2018 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
258274000
CY2018 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
1914000
CY2018 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
197366000
CY2018 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
41843000
CY2018Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
65244000
CY2018 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19054000
CY2018 amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
2500000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
843000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20710000
CY2018 amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
650000
CY2018 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
193000

Files In Submission

Name View Source Status
0001564590-19-004655-index-headers.html Edgar Link pending
0001564590-19-004655-index.html Edgar Link pending
0001564590-19-004655.txt Edgar Link pending
0001564590-19-004655-xbrl.zip Edgar Link pending
amrn-10k_20181231.htm Edgar Link pending
amrn-20181231.xml Edgar Link completed
amrn-20181231.xsd Edgar Link pending
amrn-20181231_cal.xml Edgar Link unprocessable
amrn-20181231_def.xml Edgar Link unprocessable
amrn-20181231_lab.xml Edgar Link unprocessable
amrn-20181231_pre.xml Edgar Link unprocessable
amrn-ex1069_187.htm Edgar Link pending
amrn-ex211_9.htm Edgar Link pending
amrn-ex231_12.htm Edgar Link pending
amrn-ex311_14.htm Edgar Link pending
amrn-ex312_10.htm Edgar Link pending
amrn-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gwtkewsltb1j000001.jpg Edgar Link pending
gwtkewsltb1j000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending